Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expression.

MLA

Pehlivan, Davut, et al. “Structural Variant Allelic Heterogeneity in MECP2 Duplication Syndrome Provides Insight into Clinical Severity and Variability of Disease Expression.” Genome Medicine, vol. 16, no. 1, Dec. 2024, p. 146. EBSCOhost, https://doi.org/10.1186/s13073-024-01411-7.

APA

Pehlivan, D., Bengtsson, J. D., Bajikar, S. S., Grochowski, C. M., Lun, M. Y., Gandhi, M., Jolly, A., Trostle, A. J., Harris, H. K., Suter, B., Aras, S., Ramocki, M. B., Du, H., Mehaffey, M. G., Park, K., Wilkey, E., Karakas, C., Eisfeldt, J. J., Pettersson, M., … Carvalho, C. M. B. (2024). Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expression. Genome Medicine, 16(1), 146. https://doi.org/10.1186/s13073-024-01411-7

Chicago

Pehlivan, Davut, Jesse D Bengtsson, Sameer S Bajikar, Christopher M Grochowski, Ming Yin Lun, Mira Gandhi, Angad Jolly, et al. 2024. “Structural Variant Allelic Heterogeneity in MECP2 Duplication Syndrome Provides Insight into Clinical Severity and Variability of Disease Expression.” Genome Medicine 16 (1): 146. doi:10.1186/s13073-024-01411-7.